Patents Assigned to Apollomics Inc.
  • Anti PD-L1 antibodies
    Patent number: 11827707
    Abstract: The present disclosure relates to antibodies and antigen-binding fragments thereof that bind to PD-L1, and to methods of using such antibodies and antigen-binding fragments. For example, the present invention provides humanized anti-PD-L1 antibodies and methods of use thereof.
    Type: Grant
    Filed: August 11, 2021
    Date of Patent: November 28, 2023
    Assignee: Apollomics Inc.
    Inventors: Jiping Zha, Ziyong Sun, Junzhuan Qiu
  • Anti PD-1 antibodies
    Patent number: 11560429
    Abstract: The present invention relates to antibodies and antigen-binding fragments thereof that bind to PD-1, and to methods of using such antibodies and antigen-binding fragments. For example, the present invention provides humanized anti-PD-1 antibodies and methods of use thereof.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: January 24, 2023
    Assignee: Apollomics Inc.
    Inventors: Junzhuan Qiu, Ziyong Sun, Jiping Zha
  • ANTI PD-L1 ANTIBODIES
    Publication number: 20210371531
    Abstract: The present disclosure relates to antibodies and antigen-binding fragments thereof that bind to PD-L1, and to methods of using such antibodies and antigen-binding fragments. For example, the present invention provides humanized anti-PD-L1 antibodies and methods of use thereof.
    Type: Application
    Filed: August 11, 2021
    Publication date: December 2, 2021
    Applicants: APOLLOMICS INC., APOLLOMICS INC.
    Inventors: Jiping ZHA, Ziyong SUN, Junzhuan QIU
  • Anti PD-L1 antibodies
    Patent number: 11111300
    Abstract: The present disclosure relates to antibodies and antigen-binding fragments thereof that bind to PD-L1, and to methods of using such antibodies and antigen-binding fragments. For example, the present invention provides humanized anti-PD-L1 antibodies and methods of use thereof.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: September 7, 2021
    Assignee: APOLLOMICS INC.
    Inventors: Jiping Zha, Ziyong Sun, Junzhuan Qiu
  • Anti PD-1 antibodies
    Patent number: 10981994
    Abstract: The present invention relates to antibodies and antigen-binding fragments thereof that bind to PD-1, and to methods of using such antibodies and antigen-binding fragments. For example, the present invention provides humanized anti-PD-1 antibodies and methods of use thereof.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: April 20, 2021
    Assignee: Apollomics Inc.
    Inventors: Junzhuan Qiu, Ziyong Sun, Jiping Zha